Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Jorg Wissel"'
Autor:
Philippe Lagnau, Alto Lo, Ryan Sandarage, Katharine Alter, Alessandro Picelli, Jorg Wissel, Monica Verduzco-Gutierrez, Areerat Suputtitada, Michael C. Munin, Stefano Carda, Omar Khan, Serdar Koçer, Rajiv Reebye
Publikováno v:
Toxins, Vol 13, Iss 4, p 249 (2021)
Ultrasound (US)-guided botulinum neurotoxin (BoNT) injections are becoming a mainstay in the treatment of muscle spasticity in upper motor neuron syndromes. As a result, there has been a commensurate increase in US-guided BoNT injection for spasticit
Externí odkaz:
https://doaj.org/article/0981eb8877ac43d2a6a7a2ac8a7b7740
Autor:
Jorg Wissel, Alexandre Camões-Barbosa, Georg Comes, Michael Althaus, Astrid Scheschonka, David Simpson
Publikováno v:
Thursday, April 27.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fdb6c03fbbcdb2dee311ce0bc8fb2271
https://doi.org/10.1212/wnl.0000000000202080
https://doi.org/10.1212/wnl.0000000000202080
Autor:
Jorg Wissel, Alexandre Camões-Barbosa, Georg Comes, Michael Althaus, Astrid Scheschonka, David Simpson
Publikováno v:
Wednesday, April 26.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3c134a23e327442570fb1ceae96d2d4a
https://doi.org/10.1212/wnl.0000000000202084
https://doi.org/10.1212/wnl.0000000000202084
Autor:
Jörg Wissel, Jorge Hernandez Franco
Publikováno v:
Frontiers in Neurology, Vol 15 (2024)
It is common in clinical practice to evaluate active movement in spastic movement disorders (SMDs) associated with the upper motor neuron syndrome in terms of resistance to passive movement in the rest position, with the assumption that this may refl
Externí odkaz:
https://doaj.org/article/bfa1a036ee594e44aaa1eb5c4d5ef789
Autor:
Jörg Wissel, Anatol Kivi
Publikováno v:
Annals of Rehabilitation Medicine, Vol 47, Iss 5, Pp 326-336 (2023)
Post-stroke spastic movement disorder (PS-SMD) develops in up to 40% of stroke survivors after a first ever stroke within the first year. Chronic PS-SMD is often associated with severe disabilities and complications, emphasizing the importance of its
Externí odkaz:
https://doaj.org/article/c732be8e61864d7fbbd4d64adbf30a5d
Autor:
Salvatore Facciorusso, Stefania Spina, Alessandro Picelli, Alessio Baricich, Gerard E. Francisco, Franco Molteni, Jörg Wissel, Andrea Santamato
Publikováno v:
Toxins, Vol 16, Iss 4, p 184 (2024)
Botulinum toxin type-A (BoNT-A) has emerged as a key therapeutic agent for the management of spasticity. This paper presents a comprehensive bibliometric and visual analysis of research concerning BoNT-A treatment of spasticity to elucidate current t
Externí odkaz:
https://doaj.org/article/3510a42fd568451fa9387bababdc5646
Autor:
Franco Molteni, Jörg Wissel, Klemens Fheodoroff, Michael C. Munin, Atul T. Patel, Michael Althaus, Georg Comes, Andrzej Dekundy, Irena Pulte, Astrid Scheschonka, Matteo Vacchelli, Andrea Santamato
Publikováno v:
Toxins, Vol 16, Iss 1, p 19 (2023)
A strong correlation has been reported between patient-reported quality of life (QoL) and the investigator-rated Disability Assessment Scale (DAS) in patients with spasticity. The current analysis evaluates the effect of incobotulinumtoxinA on QoL-re
Externí odkaz:
https://doaj.org/article/b07d75101faa40d3a967c412d70df326
Autor:
Rajiv Reebye, Alexander Balbert, Djamel Bensmail, Heather Walker, Jörg Wissel, Thierry Deltombe, Gerard E Francisco
Publikováno v:
The Journal of the International Society of Physical and Rehabilitation Medicine, Vol 5, Iss 5, Pp 23-37 (2022)
Spasticity management should be part of a well-coordinated and comprehensive rehabilitation program that is patient-centric and goal-specific. There are a variety of options available for the treatment of spasticity. A usual approach is starting with
Externí odkaz:
https://doaj.org/article/920a16face024ddbad6e547fba23c56e
Publikováno v:
Frontiers in Neurology, Vol 13 (2022)
IntroductionBotulinum neurotoxin type A (BoNT-A) is a first-line treatment option for post-stroke spasticity, reducing pain and involuntary movements and helping to restore function. BoNT-A is frequently injected into the arm, the wrist, the hand, an
Externí odkaz:
https://doaj.org/article/71df79ca85194717889381ad0d63307e
Publikováno v:
Frontiers in Neurology, Vol 13 (2022)
Botulinum neurotoxin type A (BoNT-A) is a first-line treatment option for post-stroke spasticity, reducing pain and involuntary movements and helping to restore function. BoNT-A is frequently injected into the arm, wrist, hand and/or finger muscles,
Externí odkaz:
https://doaj.org/article/ffeba5c71fd142ffaeffa4fd6e8900b8